Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$16,251,078
+$3,840,622 QoQ
Shares Held
13,549
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#996
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RNC CAPITAL MANAGEMENT LLC holds $281,592,319 across 11 Drug Manufacturers - General names. LLY ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
517,240 | $66,465,340 | |
| 2 | ABBV |
AbbVie Inc.
|
236,727 | $59,569,982 | |
| 3 | JNJ |
Johnson & Johnson
|
191,013 | $48,511,571 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
356,290 | $45,013,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
645,383 | $37,186,968 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
13,549 | $16,251,078 | |
| 7 | AZN |
Astrazeneca PLC
|
32,535 | $6,169,286 | |
| 8 | AMGN |
Amgen Inc
|
2,755 | $997,640 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,251,078 | 13,549 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $12,410,456 | 13,493 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $15,115,375 | 14,065 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $11,161,927 | 14,629 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,812,723 | 12,588 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $10,640,198 | 12,883 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $10,166,468 | 13,169 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $12,325,197 | 13,912 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,595,646 | 13,912 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,300,968 | 13,241 | Shares | Sole | 2024-08-07 | |
| 2023-12-31 | $8,677,930 | 14,887 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $8,051,578 | 14,990 | Shares | Sole | 2023-12-27 | |
| 2023-06-30 | $7,202,125 | 15,357 | Shares | Defined | 2023-07-21 | |
| 2023-03-31 | $5,322,666 | 15,499 | Shares | Defined | 2023-04-21 | |
| 2022-12-31 | $4,829,088 | 13,200 | Shares | Defined | 2023-01-11 | |
| 2022-09-30 | $4,643,629 | 14,361 | Shares | Defined | 2022-10-18 | |
| 2022-06-30 | $5,075,820 | 15,655 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $4,464,508 | 15,590 | Shares | Defined | 2022-07-22 | |
| 2021-12-31 | $4,366,761 | 15,809 | Shares | Defined | 2022-02-04 | |
| 2021-09-30 | $3,652,900 | 15,810 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $3,916,758 | 17,065 | Shares | Defined | 2021-07-20 | |
| 2021-03-31 | $3,741,817 | 20,029 | Shares | Defined | 2021-04-26 | |
| 2020-12-31 | $4,027,171 | 23,852 | Shares | Defined | 2021-01-13 | |
| 2020-09-30 | $3,879,456 | 26,209 | Shares | Defined | 2020-12-03 | |
| 2020-06-30 | $4,833,459 | 29,440 | Shares | Defined | 2020-07-23 | |
| 2020-03-31 | $30,755,888 | 221,712 | Shares | Defined | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||